Using 1% of stained tumor cells as positivity cut-off, 89 samples (18%) exhibited a positive MARCKS expression (≥ 1% of stained cells), whereas 413 (82%) were MARCKS-negative. This evidence concerns the gene MARCKS and neoplasm.